Cataract surgery and diabetic retinopathy

Seminars in Ophthalmology

Volumn 18, Issue 3, 2003, Pages 103-108

  Menchini, Ugo ^a   Cappelli, Stefania ^a   Virgili, Gianni ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; VASCULOTROPIN;

CATARACT EXTRACTION; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; IRIS DISEASE; LASER COAGULATION; LOW LEVEL LASER THERAPY; NEOVASCULARIZATION (PATHOLOGY); POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA MACULA EDEMA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

CATARACT; CATARACT EXTRACTION; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; IRIS; MACULAR EDEMA, CYSTOID; NEOVASCULARIZATION, PATHOLOGIC;

EID: 1642482609     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1076/soph.18.3.103.29805     Document Type: Review

References (70)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diab Med. 1997;14(5):81-85.
2. Gruber W, Lander T, Leese et al. Diabetes Health Economics Study Group: The Economics of Diabetes and Diabetes Care. Geneva: International Diabetes Federation and World Health Organization; 1997.
3. Foster A, Johnson GJ. Magnitude and causes of blindness in the developing world. Int Ophthalmol. 1990;14:135-140.
4. Munoz B, West SK, Rubin GS et al. Causes of blindness in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819-825.
5. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic study of Diabetic Retinopathy. Am J Ophthalmol. 1995;119:295-300.
6. Bron AJ, Sparrow J, Brown NA, Harding JJ, Blakitni R. The lens in diabetes. Eye. 1993;7(2):260-275.
7. UKPDS No35 Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 Aug 12;321(7258):405-412.
8. Stanga PE, Boyd SR, Hamilton AP. Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol. 1999;10:483-489.
9. Ulbig MR, Hykin PG, Foss AJ et al. Anterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction in diabetic eyes. Am J Ophthalmol. 1993;115: 321-326.
10. Ionides A, Dowler JG, Hykin PG et al. Posterior capsule opacification following diabetic extracapsular cataract extraction. Eye. 1994;8:535-537.
11. Hykin PG, Gregson RM, Stevenson JD et al. Extracapsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology. 1993;100:394-399.
12. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol. 2002 Sep-Dec;17(3-4):167-180.
13. Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol. 1992;76:221-224.
14. Benson WE, Brown GC, Tasman W et al. Extracapsular cataract extraction with placement of a posterior chamber lens in patients with diabetic retinopathy. Ophthalmology. 1993;100:730-738.
15. Irvine SR. A newly defined vitreous syndrome following cataract surgery; interpreted according to recent concepts of the structure of the vitreous. Am J Ophthalmol. 1953; 36:599-619.
16. Gass GDM, Norton EWD. Cystoid macular edema and papillaedema following cataract extraction; a fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966;76:646-661.
17. Dowler JGF, Sehmi KS, Hykin PG, Hamilton AMP. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology. 1999;106:663-668.
18. Ferguson VMG, Spalton DJ. Continued breakdown of the blood aqueous barrier following cataract surgery. Br J Ophthalmol. 1992;76:453-456.
19. Mittra RA, Borrillo JL, Dev S et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol. 2000;118:912-917.
20. Miyake K, Mibu H, Horiguchi M, Shirasawa E. Inflammatory mediators in postoperative aphakic and pseudophakic baboon eyes. Arch Ophthalmol. 1990;108:1764-1767.
21. Funatsu H, Yamashita H, Noma H, Shimizu E, Mimura T, Hori S. Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy. J Cataract Refract Surg. 2002 Aug;28(8):1355.
22. Jaffe GJ, Burton TC, Kuhn E et al. Progression of non-proliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1992;114:448-456.
23. Dowler JG, Hykin PG, Hamilton AM. Phakoemulsification versus extracapsular cataract surgery in diabetes. Ophthalmology. 2000;107:457-462.
24. Chew EY, Benson WE, Remaley NA et al. Results after lens extraction in patients with diabetic retinopathy: ETDRS Report No25. Arch Ophthalmol. 1999;117:1600-1606.
25. Kato S, Fukada Y, Hori S et al. Influence of phacoemulsification and intraocular lens implantation on the course of diabetic retinopathy. J Cataract Refract Surg. 1999;25:788-793.
26. Wagner T, Knaflic D, Rauber M, Mester U. Influence of cataract surgery on the diabetic eye: a prospective study. Ger J Ophthalmol. 1996;5:79-83.
27. Chung J, Kim MY, Kim HS, Yoo JS, Lee YC. Effect of cataract surgery on the progression of diabetic retinopathy J Cataract Refract Surg. 2002 Apr;28(4):626-630.
28. Antcliff RJ, Poulson A, Flanagan DW. Phacoemulsification in diabetics. Eye. 1996;10:737-741.
29. Sadiq A, Sleep T, Amoaku WMK. The visual results and changes in retinopathy in diabetic patients following cataract surgery. Eur J Ophthalmol. 1999;9:14-20.
30. Borillo JL, Mittra RA, Dev S et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Trans Am Ophthalmol Soc. 1999;97:435-445 discussion, 445-449.
31. Zaczek A, Olivestedt G, Zetterström C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol. 1999;83:1036-1041.
32. Krupsky S, Zalish M, Oliver M, Pollack A. Anterior segment complications in diabetic patients following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmic Surg. 1991;22:526-530.
33. Zaczek A, Zetterström C. Aqueous flare intensity after phacoemulsification in patients with diabetes mellitus. J Cataract Refract Surg. 1998;24:1099-1104.
34. Dowler GF, Hykin PG, Lightman SL, Hamilton AM, Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye. 1995;9:313-317.
35. Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus. Ophthalmology. 1983 Jul; 90(7):814-820.
36. Rice TA, Michels RG, Maguire MG, Rice EF. The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol. 1983 Jan;95(1):1-11.
37. Oshika T, Kato S, Funatsu H. Quantitative assessment of aqueous flare intensity in diabetes. Graefes Arch Clin Exp Ophthalmol. 1989;227(6):518-520.
38. Bandello F, Brancato R, Lattanzio R, Falcomata B, Malegori A. Biomicroscopy versus fluorescein angiography of the iris in the detection of diabetic iridopathy. Graefes Arch Clin Exp Ophthalmol. 1993 Aug;231(8):444-448.
39. Bandello F, Brancato R, Lattanzio R, Galdini M, Falcomata B. Relation between iridopathy and retinopathy in diabetes. Br J Ophthalmol. 1994 Jul;78(7):542-545.
40. Moffat K, Blumenkranz MS, Hernandez E. The lens capsule and rubeosis iridis: an angiographic study. Can J Ophthalmol. 1984 Apr;19(3):130-133.
41. Ino-ue M, Azumi A, Shirabe H, Yamamoto M. Iridopathy in eyes with proliferative diabetic retinopathy: detection of early stage of rubeosis iridis. Ophthalmologica. 1998;212(1):15-18.
42. Hamanaka T, Akabane N, Yajima T, Takahashi T, Tanabe A. Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy. Am J Ophthalmol. 2001 Nov;132(5):648-658.
43. Armaly MF, Baloglou PJ. Diabetes mellitus and the eye. I. Changes in the anterior segment. Arch Ophthalmol. 1967;77:485-492.
44. Madsen PH. Haemorrhagic glaucoma: comparative study in diabetic and nondiabetic patients. Br J Ophthalmol. 1971;55:444-450.
45. Ohrt V. Glaucoma due to rubeosis iridis diabetica. Ophthalmologica. 1961;142:356-365.
46. Ohnishi Y, Ishibashi T, Sagawa T. Fluorescein gonioangiography in diabetic neovascularization. Graefe's Arch Clin Exp Ophthalmol. 1994;232:199-204
47. Kimura R. Fluorescein gonioangiography. Glaucoma. 1980;2:359-367.
48. Laurell CG, Zetterstrom C, Philipson B, Syren-Nordqvist S. Randomized study of the blood-aqueous barrier reaction after phacoemulsification and extracapsular cataract extraction. Acta Ophthalmol Scand. 1998;76(5):573-578.
49. Jonas JB, Sofker A. Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization. J Cataract Refract Surg. 2002;28(11):2040-2041.
50. West JA, Dowler JG, Hamilton AM, Boyd SR, Hykin PG. Panretinal photocoagulation during cataract extraction in eyes with active proliferative diabetic eye disease. Eye. 1999;13(2):170-173.
51. Kuchle M, Handel A, Naumann GO. Cataract extraction in eyes with diabetic iris neovascularization Ophthalmic Surg Lasers. 1998;29(1):28-32.
52. Chee SP, Ti SE, Sivakumar M, Tan DT. Postoperative inflammation: extracapsular cataract extraction versus phacoemulsification. J Cataract Refract Surg. 1999;25(9): 1280-1285.
53. Minassian DC, Rosen P, Dart JK, Reidy A, Desai P, Sidhu M, Kaushal S, Wingate N. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial. Br J Ophthalmol. 2001;85(7): 822-829.
54. st century. Am J Ophthalmol. 2003;136:146-154.
55. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AM. Posterior capsule opacification. Surv Ophthalmol. 1992; 37(2):73-116.
56. Stoy VA, Fernandes M. Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses: two-year results of a randomized prospective trial. Am J Ophthalmol. 2002;133(1):167-168.
57. Trivedi RH, Werner L, Apple DJ, Pandey SK, Izak AM. Post cataract-intraocular lens (IOL) surgery opacification. Eye. 2002;16(3):217-241.
58. Bucher PJM, Büchi ER, Daicker BC, Dystrophic calcification of an implanted hydroxyethylmethacrylate intraocular lens. Arch Ophthalmol. 1995;113:1431-1435.
59. Olson RJ, Caldwell KD, Crandall AS et al. Intraoperative crystallization on the intraocular lens surface. Am J Ophthalmol. 1998;126:177-184.
60. Katai N, Yokoyama R, Yoshimura N. Progressive brown discoloration of silicone intraocular lenses after vitrectomy in a patient on amiodarone. J Cataract Refract Surg. 1999;25:451-452.
61. Werner L, Apple DJ, Escobar-Gomez M et al. Postoperative deposition of calcium on the surfaces of a hydrogel intraocular lens. Ophthalmology. 2000;107:2179-2185.
62. Yu AKFY, Shek TWH. Hydroxyapatite formation on implanted hydrogel intraocular lenses. Arch Ophthalmol. 2001;119:611-614.
63. Hollick EJ, Spalton DJ, Ursell PG, Pande MV. Biocompatibility of poly(methyl methacrylate), silicone, and AcrySof intraocular lenses: randomized comparison of the cellular reaction on the anterior lens surface. J Cataract Refract Surg. 1998;24:361-366.
64. Werner L, Apple DJ, Kaskaloglu M, Pandey SK. Dense opacification of the optical component of a hydrophilic acrylic intraocular lens; a clinicopathological analysis of 9 explanted lenses. J Cataract Refract Surg. 2001;27:1485-1492.
65. Izak AM, Werner L, Pandey SK et al. Calcifi-cation on the surface of the Bausch & Lomb Hydroview intraocular lens. Int Ophthalmol Clin. 2001;41(3):63-77.
66. Lee do H, Seo Y, Joo CK. Progressive opacification of hydrophilic acrylic intraocular lenses in diabetic patients. J Cataract Refract Surg. 2002 Jul;28(7):1271-1275.
67. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Nengl J Med. 1993;329:977-986.
68. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet. 1998;352:837-853.
69. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications intype 2 diabetes: UKPDS 38. Brit Med J. 1998;317:703-713.
70. Dowler J, Hykin PG. Cataract surgery in diabetes. Curr Opin Ophthalmol. 2001;12:175-178.